| Test |
In Range |
Out Of Range |
Units |
Reference |
| C-Reactive Protein (CRP) |
0.6 |
|
mg/L |
0 - 8.0 |
| |
CRP is useful for recognizing and monitoring inflammatory processes. Units are expressed as mg/L which is 10x classical units of mg/dL. Therefore a result of 47 mg/L is equivalent to 4.7 mg/dL. |
| |
| PSA, Free |
|
0.86 H |
ng/mL |
0 - 0.8 |
| PSA |
3.18 |
|
ng/mL |
0.0 - 4.0 |
| |
Age adjusted reference range: 70 0.0 - 6.5 |
| |
Results obtained using Siemens Healthcare Diagnostics EIA method. Numeric values obtained from other manufacturer's methods may not be used interchangeably. |
| |
| Magnesium, RBC |
5.3 |
|
mg/dL |
4.0 - 6.4 |
| |
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. |
| |
| Vitamine B1, Plasma |
21 |
|
nmol/L |
8 - 30 |
| |
Vitamin supplementation within 24 hours prior to blood draw may affect the accuracy of results. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Valencia. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. |
| |
| |
| Vitamine B6 |
12.0 |
|
ng/mL |
2.1 - 21.7 |
| |
Vitamin supplementation within 24 hours prior to blood draw may affect the accuracy of results. This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. |
| |
| Zink |
67 |
|
ug/dL |
60 - 130 |
| |
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Valencia. It has not been cleared or approved by the US Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. |
| |
| Vitamine B12 |
312 |
|
pg/mL |
211 - 911 |
| |
| Comprehensive Metabolic Panel |
|
|
|
|
| Sodium |
137 |
|
mmol/L |
136 - 145 |
| Potassium |
4.5 |
|
mmol/L |
3.5 - 5.1 |
| Chloride |
103 |
|
mmol/L |
98 - 107 |
| CO2 (Bicarbonate) |
27 |
|
mmol/L |
21 - 32 |
| Anion Gap |
7 |
|
mmol/L |
3 - 12 |
| Glucose |
85 |
|
mg/dL |
70 - 99 |
| BUN |
|
21 H |
mg/dL |
7 - 18.0 |
| Creatinine |
1.15 |
|
mg/dL |
0.5 - 1.30 |
| |
IDMS-traceable method Note New Methodology Note New Normal Range |
| |
| GFR Est. Other |
61 |
|
> 60 |
mL/min/1.73 m2 |
| |
Units: mL/min/1.73 m2. Estimated glomerular filtration rate values are calculated using the CKD-EPI equation |
| |
| Calcium |
9.0 |
|
mg/dL |
8.5 - 10.1 |
| Total Protein |
7 |
|
g/dL |
6.2 - 8.5 |
| Albumin |
4.0 |
|
g/dL |
3.4 - 5.0 |
| Total Bilirubin |
0.4 |
|
mg/dL |
< 1.1 |
| Alkaline Phosphatase |
91 |
|
U/L |
50 - 136 |
| AST |
15 |
|
U/L |
15 - 37 |
| ALT |
29 |
|
U/L |
0 - 60 |
| |
Note New Normal Range |
| |
| CEA, Carcinoembryonic Antigen |
0.7 |
|
ng/mL |
0.0 - 2.5 |
| |
Adult Non Smoker - Less than 2.5 ng/ml Adult Smoker - Less than 5.0 ng/ml Values obtained with different assay methods or kits cannot be used interchangeably. This test was performed using the Siemens Centaur methodology. |
| |
| Sedimentation Rate (ESR) |
10 |
|
mm/hr |
0 - 20 |